Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants

To the Editor A recent 2-year follow-up study of the OPTIMIST-A randomized clinical trial of preterm infants with respiratory distress syndrome found that MIST did not reduce the incidence of death or severe neurodevelopmental disability by 2 years of age. We have several concerns about the interpretation of this study ’s results.
Source: JAMA - Category: General Medicine Source Type: research